olmesartan has been researched along with adenine in 1 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (adenine) | Trials (adenine) | Recent Studies (post-2010) (adenine) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 21,903 | 1,153 | 7,682 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, E; Azushima, K; Hashimoto, T; Kamimura, D; Kinguchi, S; Nakano, M; Sano, D; Suzuki, T; Taguchi, S; Tamura, K; Tanaka, S; Tsukamoto, S; Urate, S; Wakui, H; Yamada, T; Yamaji, T; Yamashita, A | 1 |
1 other study(ies) available for olmesartan and adenine
| Article | Year |
|---|---|
Tissue-specific expression of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, in mouse models of chronic kidney disease.
Topics: Adenine; Angiotensin-Converting Enzyme 2; Animals; Aristolochic Acids; COVID-19; Disease Models, Animal; Down-Regulation; Humans; Imidazoles; Kidney; Mice; Mice, Inbred C57BL; Organ Specificity; Renal Insufficiency, Chronic; SARS-CoV-2; Tetrazoles | 2021 |